Composition
- Active ingredients
- DENOSUMAB-MOBZ 120MG/1.7ML (70MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761457.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Oziltus
- Active substance
- denosumab-mobz
- Drug class
- Other drugs affecting bone structure and mineralization
- Route
- Subcutaneous
- Dosage form
- Injectable
- Applicant
- Amneal Pharms LLC
- Status
- Prescription
- FDA approval
- 19 Dec 2025
- Application
- BLA761457-001